Seprify
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Seprify - overview
Established
2022
Location
Switzerland, -, Switzerland
Primary Industry
Materials
About
Seprify, based in Switzerland, develops innovative cellulose-based functional materials to address the increasing demand for sustainable ingredients across various industries, including cosmetics, food, and pharmaceuticals. Founded in 2022 and headquartered in Switzerland, Seprify specializes in cellulose-based solutions. The company has successfully raised EUR 13. 4 mn in its Series A funding round as of March 10, 2026, with notable investors including Cambridge Enterprise and Inter IKEA Group.
No company pivots or changes have been noted since its inception. Seprify specializes in cellulose-based functional materials designed to meet the rising demand for sustainable and high-performance ingredients across various industries. Their core product offerings include biodegradable cellulose particles that are entirely plant-based, utilized in sectors such as cosmetics, food and beverages, coatings, paints, pharmaceuticals, and nutrition. These products provide functional benefits while adhering to environmentally responsible production methods, targeting a diverse clientele in Europe and North America.
Seprify's revenue model revolves around business-to-business transactions, partnering with manufacturers and distributors across various sectors. The company generates revenue through direct sales of its cellulose-based solutions, which are positioned as premium ingredients. Long-term agreements with clients facilitate consistent supply and potential volume discounts, supporting their mission of promoting a circular bioeconomy. In March 2026, Seprify raised EUR 13.
4 mn in Series A funding to support the commercial rollout of its titanium dioxide replacement products across cosmetics, food, and coatings applications. The company aims to expand its market presence in Europe and North America, focusing on sustainable ingredient solutions. The funding will enable Seprify to enhance its product offerings and streamline its operations, facilitating entry into new markets.
Current Investors
Cambridge Enterprise, Zürcher Kantonalbank, Una Terra
Primary Industry
Materials
Sub Industries
Biomaterials
Website
www.seprify.com
Company Stage
Series A
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.